The diagnosis of amfetamine toxicity is primarily clinical. Patients usually present with sympathetic nervous system hyperactivity and a history of legitimate (licit) or illicit drug use in the immediate past.
Initial impression
Patients with amfetamine toxicity will often present with agitated, irrational, restless, and aggressive behaviour, and may show signs of hypervigilance, paranoia, and psychosis.[38]Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014 Dec;28(12):1115-26.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027896
http://www.ncbi.nlm.nih.gov/pubmed/25373627?tool=bestpractice.com
Control of behavioural disturbance may be necessary before accurate diagnosis and treatment can be attempted.[38]Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014 Dec;28(12):1115-26.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027896
http://www.ncbi.nlm.nih.gov/pubmed/25373627?tool=bestpractice.com
[39]Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015 May 1;150:1-13.
http://www.ncbi.nlm.nih.gov/pubmed/25724076?tool=bestpractice.com
In the absence of a history from the patient or another reliable historian, psychostimulant toxicity is strongly suspected in any patient with this presentation.[38]Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014 Dec;28(12):1115-26.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027896
http://www.ncbi.nlm.nih.gov/pubmed/25373627?tool=bestpractice.com
Another potential indicator of misuse of amfetamines is recent attendance at raves (youth parties with electronic dance music) and/or participation in vigorous club dancing. Club drug users are more likely to use multiple illicit substances, which may hinder a clear understanding of the clinical situation.[40]Armenian P, Mamantov TM, Tsutaoka BT, et al. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. J Intensive Care Med. 2013 Jul-Aug;28(4):252-8.
http://www.ncbi.nlm.nih.gov/pubmed/22640978?tool=bestpractice.com
[41]Yacoubian GS Jr, Peters RJ. An exploration of recent club drug use among rave attendees. J Drug Educ. 2007;37(2):145-61.
http://www.ncbi.nlm.nih.gov/pubmed/17977238?tool=bestpractice.com
[42]Fendrich M, Wislar JS, Johnson TP, et al. A contextual profile of club drug use among adults in Chicago. Addiction. 2003 Dec;98(12):1693-703.
http://www.ncbi.nlm.nih.gov/pubmed/14651501?tool=bestpractice.com
Rave attendees are more likely to report frequent use of 3,4-methylenedioxymethamfetamine.[42]Fendrich M, Wislar JS, Johnson TP, et al. A contextual profile of club drug use among adults in Chicago. Addiction. 2003 Dec;98(12):1693-703.
http://www.ncbi.nlm.nih.gov/pubmed/14651501?tool=bestpractice.com
Poor dentition ('meth mouth') may also provide clues to potential misuse of amfetamines.[43]De-Carolis C, Boyd GA, Mancinelli L, et al. Methamphetamine abuse and "meth mouth" in Europe. Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20(2):e205-10.
https://www.medicinaoral.com/pubmed/medoralv20_i2_p205.pdf
http://www.ncbi.nlm.nih.gov/pubmed/25662544?tool=bestpractice.com
[44]Richards JR, Brofeldt BT. Patterns of tooth wear associated with methamphetamine use. J Periodontol. 2000 Aug;71(8):1371-4.
http://www.ncbi.nlm.nih.gov/pubmed/10972655?tool=bestpractice.com
History
Significant risk for amfetamine overdose is imparted by known risk factors, such as exposure to high temperature, exercise, sweating and volume depletion, attendance at dance club or rave party, polydrug and alcohol usage, anxiety, depression, behavioural deviation or criminality, and ADHD.[31]Russell K, Dryden DM, Liang Y, et al. Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatr. 2008 Oct 28;8:48.
https://www.biomedcentral.com/1471-2431/8/48
http://www.ncbi.nlm.nih.gov/pubmed/18957076?tool=bestpractice.com
[33]Cumming C, Troeung L, Young JT, et al. Barriers to accessing methamphetamine treatment: a systematic review and meta-analysis. Drug Alcohol Depend. 2016 Nov 1;168:263-73.
http://www.ncbi.nlm.nih.gov/pubmed/27736680?tool=bestpractice.com
If the patient is cooperative, or a reliable history can be obtained from family or friends, a detailed drug history may reveal prior drug misuse, a known risk factor for amfetamine overdose. Questioning includes immediate and past use, type, route, amount, and time and potency (e.g., length and intensity of effect) of the ingested drug. Polydrug use is common (e.g., alcohol, cannabis, cocaine, and heroin), which may confuse and complicate the clinical picture.[27]Schifano F, Corkery J, Naidoo V, et al. Overview of amphetamine-type stimulant mortality data - UK, 1997-2007. Neuropsychobiology. 2010 Mar;61(3):122-30.
http://www.ncbi.nlm.nih.gov/pubmed/20110737?tool=bestpractice.com
[45]Degenhardt L, Coffey C, Carlin JB, et al. Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction. 2007 Aug;102(8):1269-79.
http://www.ncbi.nlm.nih.gov/pubmed/17624977?tool=bestpractice.com
[46]Sterk CE, Theall KP, Elifson KW. Getting into ecstasy: comparing moderate and heavy young adult users. J Psychoactive Drugs. 2007 Jun;39(2):103-13.
http://www.ncbi.nlm.nih.gov/pubmed/17703705?tool=bestpractice.com
All possibilities for drug misuse are investigated, including prescription medications.[40]Armenian P, Mamantov TM, Tsutaoka BT, et al. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. J Intensive Care Med. 2013 Jul-Aug;28(4):252-8.
http://www.ncbi.nlm.nih.gov/pubmed/22640978?tool=bestpractice.com
[41]Yacoubian GS Jr, Peters RJ. An exploration of recent club drug use among rave attendees. J Drug Educ. 2007;37(2):145-61.
http://www.ncbi.nlm.nih.gov/pubmed/17977238?tool=bestpractice.com
[42]Fendrich M, Wislar JS, Johnson TP, et al. A contextual profile of club drug use among adults in Chicago. Addiction. 2003 Dec;98(12):1693-703.
http://www.ncbi.nlm.nih.gov/pubmed/14651501?tool=bestpractice.com
It is very important to identify those patient medications that may interact with amfetamines to cause serotonin toxicity (e.g., serotonin-reuptake inhibitors, metoclopramide, sumatriptan, lithium, dextromethorphan).[29]Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013 Sep 4;25(3):193-9.
http://www.ncbi.nlm.nih.gov/pubmed/24006318?tool=bestpractice.com
[47]Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003 Sep;96(9):635-42.
https://qjmed.oxfordjournals.org/content/96/9/635.full
http://www.ncbi.nlm.nih.gov/pubmed/12925718?tool=bestpractice.com
Symptoms such as palpitations and chest pain bear particular scrutiny. An overdose of amfetamines may increase myocardial oxygen demand (through increased heart rate, contractility, and wall tension), leading to increased risk of acute myocardial infarction, ischaemia, and dysrhythmia.[39]Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015 May 1;150:1-13.
http://www.ncbi.nlm.nih.gov/pubmed/25724076?tool=bestpractice.com
[48]Suarez RV, Riemersma R. "Ecstasy" and sudden cardiac death. Am J Forensic Med Pathol. 1988 Dec;9(4):339-41.
http://www.ncbi.nlm.nih.gov/pubmed/3239555?tool=bestpractice.com
[49]Turnipseed SD, Richards JR, Kirk JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003 May;24(4):369-73.
http://www.ncbi.nlm.nih.gov/pubmed/12745036?tool=bestpractice.com
Abdominal pain may suggest mesenteric ischaemia or possible drug ingestion in bulk with gastrointestinal obstruction.[50]Johnson TD, Berenson MM. Methamphetamine-induced ischemic colitis. J Clin Gastroenterol. 1991 Dec;13(6):687-9.
http://www.ncbi.nlm.nih.gov/pubmed/1761842?tool=bestpractice.com
A headache may be the initial finding of subarachnoid haemorrhage or intracerebral bleeding. Pertinent findings from the medical history include exposure to hepatitis B, hepatitis C, or HIV (indirect indicators of high-risk lifestyle); traumatic physical injuries, which are common in the setting of drug misuse; and underlying (possibly untreated) psychiatric illness (e.g., anxiety, depression).
Examination
Objective signs may be the sole clues to amfetamine overdose if the patient is not cooperative or does not acknowledge psychostimulant use, or if corroborative history is not available. Signs of amfetamine intoxication include:[8]Carvalho M, Carmo H, Costa VM, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012 Aug;86(8):1167-231.
http://www.ncbi.nlm.nih.gov/pubmed/22392347?tool=bestpractice.com
[9]Harro J. Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol. 2015;120:179-204.
http://www.ncbi.nlm.nih.gov/pubmed/26070758?tool=bestpractice.com
[16]Fleckenstein AE, Volz TJ, Riddle EL, et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007 Feb 10;47:681-98.
http://www.ncbi.nlm.nih.gov/pubmed/17209801?tool=bestpractice.com
[23]Schep LJ, Slaughter RJ, Beasley DM. The clinical toxicology of metamfetamine. Clin Toxicol (Phila). 2010 Aug;48(7):675-94.
http://www.ncbi.nlm.nih.gov/pubmed/20849327?tool=bestpractice.com
[38]Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014 Dec;28(12):1115-26.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027896
http://www.ncbi.nlm.nih.gov/pubmed/25373627?tool=bestpractice.com
Tachycardia
Hyperthermia (if >39.5°C [>103°F]) may indicate severe, life-threatening toxicity, and immediate cooling and sedation are necessary
Volume depletion
Extreme agitation or acute behavioural disturbance
Seizures
Altered level of consciousness (e.g., disorientation, confusion, delirium)
Severe headache
Hypertension
Respiratory difficulties (e.g., tachypnoea, dyspnoea)
Chest pain or cardiac arrhythmias.
Flushed facial skin in the presence of pyrexia may be an early finding on exam, supporting the diagnosis of amfetamine toxicity. Volume depletion is typical of dancing activities or physical exertion in hot, crowded social venues. Paradoxically, stimulants may mask thirst and actually decrease fluid consumption, thereby exacerbating the degree of volume depletion.[51]Baggott MJ. Preventing problems in Ecstasy users: reduce use to reduce harm. J Psychoactive Drugs. 2002 Apr-Jun;34(2):145-62.
http://www.ncbi.nlm.nih.gov/pubmed/12691205?tool=bestpractice.com
Behavioural and mental disturbance may be a manifestation of underlying psychiatric illness or hyperactivity of the sympathetic nervous system. Seizures may accompany haemodilution and hyponatraemia with cerebral oedema, as may headache. Respiratory symptoms (e.g., tachypnoea) may occur in the context of cardiovascular compromise or as acute respiratory distress syndrome (ARDS). ARDS is a familiar sequel to hyperthermia with findings similar to those of heat stroke (high temperature, metabolic acidosis, renal failure). Tachycardia with or without arrhythmias, with increased cardiac workload, may lead to heart failure.[39]Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015 May 1;150:1-13.
http://www.ncbi.nlm.nih.gov/pubmed/25724076?tool=bestpractice.com
[52]Jafari Giv M. Exposure to amphetamines leads to development of amphetamine type stimulants associated cardiomyopathy (ATSAC). Cardiovasc Toxicol. 2017 Jan;17(1):13-24.
http://www.ncbi.nlm.nih.gov/pubmed/27663745?tool=bestpractice.com
[53]Sliman S, Waalen J, Shaw D. Methamphetamine-associated congestive heart failure: increasing prevalence and relationship of clinical outcomes to continued use or abstinence. Cardiovasc Toxicol. 2016 Oct;16(4):381-9.
http://www.ncbi.nlm.nih.gov/pubmed/26661075?tool=bestpractice.com
[54]Won S, Hong RA, Shohet RV, et al. Methamphetamine-associated cardiomyopathy. Clin Cardiol. 2013 Dec;36(12):737-42.
https://onlinelibrary.wiley.com/doi/10.1002/clc.22195/full
http://www.ncbi.nlm.nih.gov/pubmed/24037954?tool=bestpractice.com
[55]Akhgari M, Mobaraki H, Etemadi-Aleagha A. Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths. Daru. 2017 Feb 17;25(1):5.
https://darujps.biomedcentral.com/articles/10.1186/s40199-017-0170-4
http://www.ncbi.nlm.nih.gov/pubmed/28212679?tool=bestpractice.com
Other signs may include:
Clenched jaw (trismus)
Muscle rigidity
Tremor or repetitive movements
Rapid speech
Pacing
Diaphoresis
Hallucinations or delusions
Dilated pupils that react sluggishly to light.
Long-standing regular drug use may be indicated by obvious signs of poor nutrition and evidence of needle marks or thrombophlebitis in the extremities. Signs of traumatic injury may also be present, as it is common in drug toxicity. Subarachnoid haemorrhage is an unusual but known presentation in amfetamine overdose, and mandates careful assessment of the eye grounds for papilloedema and survey for focal neurological signs.
Signs of serotonin toxicity
Serotonin toxicity may manifest clinically as the following:[29]Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013 Sep 4;25(3):193-9.
http://www.ncbi.nlm.nih.gov/pubmed/24006318?tool=bestpractice.com
[47]Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003 Sep;96(9):635-42.
https://qjmed.oxfordjournals.org/content/96/9/635.full
http://www.ncbi.nlm.nih.gov/pubmed/12925718?tool=bestpractice.com
Stimulation of the central nervous system may incite agitation and tremor. Clonus and bilateral Babinski's signs also characterise serotonin toxicity, with neuromuscular findings typically more pronounced in the lower extremities.
Laboratory tests
Fingerstick glucose level is done immediately at the bedside to exclude hypoglycaemia. Formal laboratory investigations may include:
Serum electrolytes, glucose, urea, creatinine, liver function tests, prothrombin time, PTT, INR, creatine kinase, brain natriuretic peptide, and troponin[56]Jones AL, Dargan PI. Churchill's textbook of toxicology. Edinburgh, UK: Churchill-Livingstone; 2001.
Urinalysis (dipstick may cross-react positive for blood in rhabdomyolysis)[56]Jones AL, Dargan PI. Churchill's textbook of toxicology. Edinburgh, UK: Churchill-Livingstone; 2001.
Urine sample for drug screen (detects drug use over the past several days)[57]Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group (2017) Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health
https://www.gov.uk/government/publications/drug-misuse-and-dependence-uk-guidelines-on-clinical-management
Breath alcohol test or serum alcohol level.
Imaging
Depending on the presentation and findings, and in some cases intuition, the following imaging exams may be appropriate:
Chest x-ray if the patient has chest pain or dyspnoea
Low-dose CT scan (LDCT) of the abdomen and pelvis (may reveal drug packages from body packing or body stuffing)[58]Royal College of Emergency Medicine. Management of suspected internal drug trafficker. Dec 2020 [internet publication].
https://rcem.ac.uk/wp-content/uploads/2021/10/Management_of_Suspected_Internal_Drug_Trafficker_December_2020.pdf
CT or MRI of the head (in patients with severe headache, altered states of consciousness, seizures, or neurological sign unexplained by serotonin toxicity); CT is more commonly the initial cranial imaging modality, because MRI is more difficult and time-consuming while trying to manage amfetamine overdose acutely, although it is better at identifying lesions at the grey-white interface
Cerebral angiography in patients <40 years with non-traumatic intracerebral haemorrhage, as an increase in noradrenaline (norepinephrine) prompts cardiovascular effects, most notably hypertension, with risk of central nervous system haemorrhage and stroke.[2]Moon K, Albuquerque FC, Mitkov M, et al. Methamphetamine use is an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurointerv Surg. 2015 May;7(5):346-50.
http://www.ncbi.nlm.nih.gov/pubmed/24780822?tool=bestpractice.com
Other
ECG is routinely obtained in all patients. Patients with chest pain, tachycardia, or arrhythmia also undergo continuous cardiac monitoring.[23]Schep LJ, Slaughter RJ, Beasley DM. The clinical toxicology of metamfetamine. Clin Toxicol (Phila). 2010 Aug;48(7):675-94.
http://www.ncbi.nlm.nih.gov/pubmed/20849327?tool=bestpractice.com
[39]Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015 May 1;150:1-13.
http://www.ncbi.nlm.nih.gov/pubmed/25724076?tool=bestpractice.com
[48]Suarez RV, Riemersma R. "Ecstasy" and sudden cardiac death. Am J Forensic Med Pathol. 1988 Dec;9(4):339-41.
http://www.ncbi.nlm.nih.gov/pubmed/3239555?tool=bestpractice.com
[49]Turnipseed SD, Richards JR, Kirk JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003 May;24(4):369-73.
http://www.ncbi.nlm.nih.gov/pubmed/12745036?tool=bestpractice.com